HealthQuill Health
Health Medical Research

Global prevalence of autism reaches 61.8 million: Study

HQ Team December 30, 2024: The global prevalence and health burden of autism spectrum disorder (ASD) are high, according to a review published.

Read More
AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival
Climate Health Medical

Plastic pollution has increased breast cancer rates globally

HQ Team December 30, 2024: Researchers have identified a strong link between plastics and the rising incidence of breast cancer. Breast cancer has.

Read More
Health Medical Research

Study reveals early signs of Multiple Sclerosis in children

Bharti Jayshankar December 28, 2024: A recent research reveals that certain symptoms precede a diagnosis of multiple sclerosis (MS) in pediatric patients. The.

Read More
A 56-year-old woman from China's Guangdong province died on March 16 after being infected with avian influenza, AH3N8, sparking the world's most populous nation to enforce control and preventive measures.
Health Medical

Mutations in severe H5N1 bird flu infection in humans worrisome: CDC

Bharti Jayshankar December 28, 2024: The Centers for Disease Control and Prevention (CDC) has identified mutations in genetic sequences from a patient in.

Read More
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Health Medical

Sleeping pills show promise in reducing Alzheimer’s proteins

HQ Team December 28, 2024: Research has shown a potential connection between the progression of Alzheimer’s disease in people who take sleeping pills..

Read More
Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s damaged blood vessel after a traumatic injury.
Drugs Health Medical Pharma

Humacyte’s tissue-engineered blood vessel for vascular trauma gets nod

Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s.

Read More
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six years and older, according to a statement from the company.
Drugs Health Medical Research

Vertex gets US regulator’s nod for extended use of cystic fibrosis drug

Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six.

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Health Pharma

Ionis Pharma’s drug to treat rare genetic disease gets US regulator’s nod 

The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia.

Read More
US-based Merck Inc., two late-stage studies have met the main efficacy goal of suppressing the HIV-1 virus in adults receiving different antiretroviral therapies, according to a company statement.
Drugs Health Medical Pharma

Merck’s end-stage studies meet efficacy goal of suppressing HIV-1 virus

US-based Merck Inc., two late-stage studies have met the main efficacy goal of suppressing the HIV-1 virus in adults receiving different antiretroviral therapies,.

Read More
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a new target date set for March next year.
Health

New research links food allergies to atopic dermatitis in children

HQ Team December 19, 2024: Recent studies have revealed a significant relationship between food allergies and atopic dermatitis (AD) in pediatric patients, indicating.

Read More